Novartis India

50
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,472.40
3.85 (0.26%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 81.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
819.00
-463.00
-56.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
819.00
-463.00
-56.53%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-24.00
27.00
112.50%
Raw Materials Consumed
199.00
399.00
-200.00
-50.13%
Power & Fuel Cost
0.00
18.00
-18.00
-100.00%
Employee Cost
18.00
127.00
-109.00
-85.83%
Operating Expenses
8.00
29.00
-21.00
-72.41%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
47.00
-37.00
-78.72%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
11.00
-2.00
-18.18%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
683.00
-419.00
-61.35%
Operating Profit (PBDIT) excl Other Income
91.00
136.00
-45.00
-33.09%
Other Income
41.00
3.00
38.00
1,266.67%
Operating Profit (PBDIT)
133.00
140.00
-7.00
-5.00%
Interest
0.00
24.00
-24.00
-100.00%
Profit before Depriciation and Tax
132.00
115.00
17.00
14.78%
Depreciation
2.00
21.00
-19.00
-90.48%
Profit Before Taxation & Exceptional Items
130.00
94.00
36.00
38.30%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
94.00
36.00
38.30%
Provision for Tax
29.00
24.00
5.00
20.83%
Profit After Tax
100.00
69.00
31.00
44.93%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
352.00
376.00
106.82%
Profit Available for appropriations
829.00
422.00
407.00
96.45%
Appropriations
829.00
422.00
407.00
96.45%
Equity Dividend (%)
500%
10%
490.00
Earnings Per Share
40.87
6.97
33.90
486.37%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024